Life Sciences

Ivanhoé Cambridge and Lendlease celebrated the completion of a $545 million life sciences center in Boston in June of 2025. Designed by SGA, FORUM strategically integrates Class A laboratory environments with collaborative workspaces and engaging community amenities. The 350,000-rsf facility offers flexible floor plates spanning 50,000 sf, supported by robust infrastructure to meet the demands of next-generation research programs.

Gilead Sciences is constructing the Cancer Research Center in Foster City to accelerate the creation of novel solutions for pressing medical challenges. Driven by the company's enterprise master plan, the project is part of a strategic initiative to develop an internal research infrastructure that advances discovery in key focus areas and brings new technological capabilities in-house. The 182,000-sf facility was designed by Gensler to catalyze synergies between 54 clinical programs spanning oncology, inflammation, and virology.

AstraZeneca opened a $300 million cell therapy facility in May of 2025 in Rockville, Md. Developed by Alexandria Real Estate Equites, the 84,264-rsf building features specialized environments for the production of chimeric antigen receptor therapies (CAR-T) and T-cell receptor therapies (TCR-T). Next-generation biomanufacturing suites will leverage advanced process controls to create life-saving personalized medicine treatments, spanning every step from culturing and formulation to testing.

The University of California, Davis celebrated the opening of a $1.1 billion destination for collaborative discovery in May of 2025 in Sacramento. Spanning 767,000 sf, the first phase of Aggie Square was designed by ZGF Architects as the flagship for a new model of innovation district that strategically collocates academic, industry, and community partners not only in the same building, but in many cases on the same floor.

Bruntwood SciTech opened Citylabs 4.0 in March of 2025 in Manchester in the United Kingdom. Created in partnership with Manchester University NHS Foundation Trust (MFT), the £42 million ($55.3 million) facility promises to catalyze breakthroughs in precision medicine, healthcare, and the life sciences. The development’s strategic colocation with MFT in the city’s biomedical cluster enables direct access to joint clinical trials, diagnostic collaborations, and advanced resources to accelerate the discovery and implementation of healthcare innovations.

Simmons University is partnering with Skanska to create Longwood Place, a vibrant nexus for research, work, and community engagement in Boston. Featuring 2.6 acres of public space, the mixed-use project will leverage sophisticated amenities to transform the district into a destination for economic growth and innovation. The redevelopment of the university’s residential campus in Fenway will provide over 1.3 million sf of Class A lab and office environments, retail and community venues, and approximately 380 housing units.

Brandywine Realty Trust has completed construction on 3151 Market Street, a dynamic innovation facility in the heart of Philadelphia’s life sciences cluster. Designed by Gensler, the 472,000-sf tower offers purpose-built offices and customizable laboratories with options for chemical and biological use, GMP production, and vivarium operations. Collaboration and knowledge exchange are enhanced by an advanced conference center and a café, complemented by private terraces and green spaces to amplify employee productivity.

Roche announced the launch of the Roche Genentech Innovation Center in March of 2025 on Harvard’s Enterprise Research Campus in Allston. With an initial lease of 30,000 sf of lab space in the first phase of construction, Roche intends to expand their R&D presence to eventually accommodate 500 employees. The initiative will bring together cardiovascular, renal, and metabolism experts with data science and AI specialists to accelerate innovation in drug discovery and development.

BioMed Realty is constructing a 637,000-sf life sciences facility in Cambridge for Takeda Pharmaceuticals. Designed by CBT Architects, the 16-story structure will provide advanced lab and office environments to accelerate the creation of innovative therapies and vaccines. Featuring flexible spaces to optimize in-person interaction and connection in a hybrid working model, the leased building furthers Takeda’s goal of unifying their Global R&D Center in Kendall Square.

Ohio University began construction in January of 2025 on the $75 million Heritage Translational Research Center (HTRC) in Athens. Designed by Perkins&Will and DesignGroup, the 80,000-sf facility will consolidate laboratories and operations currently dispersed across campus, creating a collaborative ecosystem for clinical innovation. The four-story structure will provide bench space for translational biomedical research, as well as labs and support spaces for population health and clinical research.

Leggat McCall Properties and DLJ Real Estate Capital Partners opened a 370,000-rsf life sciences building at Boynton Yards in Somerville in November of 2024. Strategically sited less than a mile from Kendall Square, 808 Windsor was designed by ARC/Architectural Resources Cambridge as a catalyst for biomedical and pharmaceutical innovation. JLL Capital Markets arranged $246 million in construction financing for the project with capital partner Deutsche Finance America.

The vision of biomedical research as a collective effort is resoundingly clear in the $237.5 million Pelotonia Research Center, the first building to be completed in the 350-plus-acre Carmenton district on the campus of The Ohio State University (Ohio State) in Columbus. Opened in May 2023, the center integrates almost 100,000 sf of wet labs, 25,000 sf of computational labs, and 20,000 sf of core labs in a single facility designed to host interdisciplinary collaborations and public-private initiatives that focus on solving some of the most critical health challenges. With life science as the backbone of the research endeavor, current projects range from modeling cancer progressions to 3D printing of patient-specific anatomic models. 

The Sam and Ann Barshop Institute for Longevity and Aging Studies at the University of Texas Health in San Antonio illustrates the pivotal role location plays in enhancing the success of an internationally recognized research program. The Institute previously occupied two buildings at a research park 23 miles from the university’s main campus. University administrators wanted to collocate all research on the same campus to promote multidisciplinary collaboration and interaction, with proximity to all clinical research activities, and to promote efficiency and the shared use of resources. 

Attovia Therapeutics is relocating to 26,000 sf at Brittan West, a recently completed life sciences center in San Carlos, Calif. JLL acted as leasing agent for the facility, which will enable the company to expand its research activities and accelerate the creation of novel biotherapeutics for immune-mediated diseases. Access to world-class amenities will enhance collaboration and optimize the employee experience.